Skip to Content
Merck
  • Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.

Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.

European journal of pharmacology (2012-04-03)
Orit Bar-Am, Aviva Gross, Rachel Friedman, John P M Finberg
ABSTRACT

Cardiovascular baroreceptor responsiveness of conscious rats treated with selective inhibitors of monoamine oxidase (MAO) types A and B was determined by measurement of blood pressure (BP) and heart rate (HR) responses to intravenous injection of phenylephrine and sodium nitroprusside. Treatment with selegiline (1 or 5 mg/kg p.o. daily for 7 days) did not significantly modify resting levels of BP and HR, lower or upper HR plateau levels, or HR/BP gain. Treatment with clorgyline (2 mg/kg p.o. daily for 7 days) increased HR/BP gain but also did not modify resting BP or HR, or lower and upper plateau levels of HR. The results are compatible with an effect of MAO-A inhibition to modify monoamine levels in medullary areas participating in CNS control of blood pressure.

MATERIALS
Product Number
Brand
Product Description

Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity